Coramaze Technologies said it raised a $5 million (€4.5 million) Series A round for the transcatheter mitral valve implant it’s developing. The round was led by a $3.9 million (€3.5 million) contribution from Israel’s Elron Electronic Industries (TASE:ELRN), which said it now owns 28% of Munich-based Coramaze. Existing backers High-Tech Gründerfonds and SeedCapital Dortmund also participated with a pool of private investors, […]